Since the increased motility and invasiveness of metastatic carcinomas directly correlates with the expression of certain pro-metastatic adhesion molecules [59], we next examined whether inhibition of UCH-L1 DUB activity will down-regulate established metastatic markers such as N-cadherin, β-catenin and CD44. The gene discussed is UCHL1; the disease is metastatic carcinoma.